Tuberculosis

Scope & Guideline

Advancing knowledge in the fight against tuberculosis.

Introduction

Delve into the academic richness of Tuberculosis with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1472-9792
PublisherCHURCHILL LIVINGSTONE
Support Open AccessNo
CountryUnited States
TypeJournal
Converge1974, from 2001 to 2024
AbbreviationTUBERCULOSIS / Tuberculosis
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressJOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND

Aims and Scopes

The journal 'Tuberculosis' focuses on advancing the understanding, diagnosis, treatment, and prevention of tuberculosis (TB) and its causative agent, Mycobacterium tuberculosis. It encompasses a wide range of research areas, from molecular biology to clinical studies, reflecting the complexity of TB as a global health issue.
  1. Pathogenesis and Immunology of Tuberculosis:
    Research on the mechanisms by which Mycobacterium tuberculosis infects the host, evades the immune response, and the resulting immunological responses, including T-cell diversity and macrophage interactions.
  2. Clinical Diagnosis and Biomarkers:
    Studies focused on the development and validation of diagnostic tools and biomarkers for tuberculosis detection, including blood tests, imaging techniques, and molecular assays.
  3. Drug Resistance and Treatment Strategies:
    Exploration of drug-resistant strains of tuberculosis, mechanisms of resistance, and the evaluation of new therapeutic agents and treatment regimens to combat TB.
  4. Epidemiology and Public Health:
    Research on the epidemiological aspects of tuberculosis including transmission patterns, prevalence in different populations, and the impact of TB on public health.
  5. Vaccine Development and Immunization Strategies:
    Investigations into novel vaccines, their efficacy, mechanisms of action, and the role of host immunity in vaccine-induced protection against tuberculosis.
  6. Environmental and Zoonotic Aspects of Mycobacteria:
    Studies exploring non-tuberculous mycobacteria, their environmental reservoirs, and zoonotic transmission dynamics.
The journal has shown a dynamic evolution in its focus, with several emerging themes gaining traction in recent years. These trends reflect the ongoing challenges and advancements in tuberculosis research.
  1. Host-Directed Therapies and Immunotherapy:
    An increasing focus on therapies that enhance the host's immune response to tuberculosis, including novel adjunct therapies and biomarker identification that may guide treatment.
  2. Molecular and Genetic Characterization of Strains:
    A growing emphasis on understanding the genetic diversity and molecular mechanisms of drug resistance in Mycobacterium tuberculosis, facilitating targeted treatment approaches.
  3. Impact of Comorbidities on Tuberculosis:
    Research exploring the interplay between tuberculosis and other conditions, such as diabetes and HIV, is becoming more prevalent, highlighting the need for integrated management strategies.
  4. Advanced Diagnostic Techniques:
    There is a significant trend towards the development of rapid and sensitive diagnostic methods, including genomic and proteomic approaches, which are essential for timely TB detection.
  5. Environmental and Zoonotic Mycobacteria:
    Emerging studies on non-tuberculous mycobacteria and their interactions with human health and the environment are gaining attention, reflecting a broader understanding of mycobacterial diseases.

Declining or Waning

While 'Tuberculosis' continues to cover a vast array of topics, certain themes appear to be declining in frequency or prominence in recent publications. This may reflect shifting research priorities or the maturation of certain areas of study.
  1. Historical Perspectives on Tuberculosis:
    Research focusing on the historical aspects and archaeological findings related to tuberculosis, while still relevant, appears to be less frequent as the journal shifts towards more contemporary issues of TB management and treatment.
  2. Non-Clinical Models of Tuberculosis:
    Studies utilizing animal models or in vitro systems for understanding TB dynamics are becoming less emphasized compared to clinical and epidemiological studies, indicating a potential waning interest in non-human models.
  3. General Microbiology of Mycobacteria:
    While the microbiological aspects of Mycobacterium species remain important, there is a noticeable decrease in non-specific microbiological studies, possibly due to a more targeted focus on tuberculosis-specific research.

Similar Journals

IMMUNOBIOLOGY

Elevating research standards in the fields of immunity and hematology.
Publisher: ELSEVIER GMBHISSN: 0171-2985Frequency: 12 issues/year

IMMUNOBIOLOGY is a prestigious academic journal published by Elsevier GmbH that significantly contributes to the fields of hematology and immunology. With its ISSN 0171-2985 and E-ISSN 1878-3279, this journal has been disseminating impactful research since 1979, positioning itself at the forefront of immunological and hematological advances. The journal holds a commendable ranking of Q2 in Hematology and Q3 in both Immunology and Immunology and Allergy, indicating its relevance and influence within the scientific community, as reflected by its Scopus rankings. Although IMMUNOBIOLOGY operates under a subscription model, it remains dedicated to expanding knowledge across disciplines, fostering innovative research, and facilitating connections among researchers, professionals, and students. Situated in Munich, Germany, this journal is continually evolving and aims to remain an essential resource for the latest discoveries and insights in the realms of immunity and blood disorders, ultimately enhancing our understanding of complex biological systems.

JOURNAL OF INFECTIOUS DISEASES

Advancing the Frontiers of Infectious Disease Research
Publisher: OXFORD UNIV PRESS INCISSN: 0022-1899Frequency: 24 issues/year

The JOURNAL OF INFECTIOUS DISEASES, published by OXFORD UNIV PRESS INC, is a leading peer-reviewed journal dedicated to advancing the understanding of infectious diseases through high-quality research. With an impressive impact factor reflecting its prominence in the field—ranking in the Q1 category for both Immunology and Allergy and Infectious Diseases—this journal serves as a pivotal platform for researchers, healthcare professionals, and students alike. Its extensive history, spanning over a century since its inception in 1904, highlights its established authority and commitment to the field. Based in the United Kingdom, the journal covers essential topics from clinical management to epidemiological trends, providing vital insights that inform practice and policy. Although the journal is not open access, it remains accessible to a wide audience, ensuring that critical research continues to drive innovation and best practices in infectious disease management.

INFECTION AND IMMUNITY

Empowering Researchers with Cutting-Edge Discoveries
Publisher: AMER SOC MICROBIOLOGYISSN: 0019-9567Frequency: 12 issues/year

INFECTION AND IMMUNITY is a distinguished peer-reviewed journal published by the American Society for Microbiology, focusing on groundbreaking research in the fields of infection, immunology, microbiology, and parasitology. Established in 1971, this journal has built a robust legacy, converging years of scientific discovery with a vision towards 2024 and beyond. With an impressive Impact Factor, the journal holds significant rankings in various categories; its Q1 status in both Infectious Diseases and Parasitology underscores its high relevance and quality within the scientific community. Researchers and professionals alike will benefit from its content, as it promotes the latest advances in understanding immune responses and infectious agents, further legitimizing its place among the top quartiles of its respective fields. Access options are provided through traditional subscription models, ensuring a broad charitable dissemination of knowledge. As a pivotal resource for scholars and practitioners alike, INFECTION AND IMMUNITY stands at the forefront of microbiological and immunological research, fostering essential discourse that is crucial for advancing public health and scientific insight.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Exploring the Frontiers of Immune System Science
Publisher: WILEYISSN: 0300-9475Frequency: 12 issues/year

Scandinavian Journal of Immunology is a prestigious peer-reviewed journal published by Wiley, focused on the evolving field of immunology and its interdisciplinary ties with medicine. Since its inception in 1972, this journal has cultivated a rich repository of knowledge, showcasing innovative research and reviews that contribute to the understanding of immune system functions, disorders, and therapeutic interventions. With an impressive impact factor reflecting a Q2 ranking in Immunology and a top-tier Q1 status in miscellaneous Medicine categories for 2023, it is recognized for its high-quality scholarly output, positioning it among the leading journals in the field. Additionally, its Scopus ranking of #84 out of 236 in Immunology underscores its significance and relevance to both emerging and established researchers. Although it does not currently offer open access options, the journal’s expansive reach and rigorous publication standards make it an essential platform for disseminating impactful research to the global scientific community. The journal invites submissions that explore the complexities of the immune system, aiming to bridge clinical and basic science for a comprehensive understanding of immunological phenomena.

COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES

Exploring Host-Pathogen Dynamics for Global Health
Publisher: ELSEVIER SCI LTDISSN: 0147-9571Frequency: 6 issues/year

Comparative Immunology Microbiology and Infectious Diseases, published by Elsevier Science Ltd, is a prominent journal dedicated to advancing the fields of immunology, microbiology, infectious diseases, and veterinary sciences. Established in 1978, this journal has become a vital resource for researchers and professionals alike, with a commendable impact factor that reflects its significance in academia. The journal, available in both print and electronic formats (ISSN: 0147-9571, E-ISSN: 1878-1667), stands out for its commitment to disseminating innovative research findings, particularly through its categorization in Q2 and Q3 quartiles across various related disciplines as of 2023. The journal aims to provide insightful comparative analyses that enhance our understanding of host-pathogen interactions, immune responses, and disease manifestations. With a global readership base, it serves as a platform for collaborative discourse among scientists and professionals, ultimately contributing to the improvement of health outcomes worldwide.

INFECTION

Advancing the Science of Infectious Diseases
Publisher: SPRINGER HEIDELBERGISSN: 0300-8126Frequency: 6 issues/year

INFECTION is a prestigious journal, published by Springer Heidelberg, that serves as a leading platform for the dissemination of critical research in the fields of Infectious Diseases, Microbiology, and Medicine. With an impressive Q1 ranking in multiple categories such as Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology, the journal is recognized for its high-quality content and impactful contributions to the scientific community, as evidenced by its Scopus rankings placing it in the top 10th percentiles. Since its inception in 1973, and projected to continue until 2024, INFECTION has established itself as a vital resource for researchers, healthcare professionals, and students keen to explore the latest findings and advancements in infectious diseases. The journal provides a rigorous peer-review process, ensuring that only high-quality studies are published, making it an essential read for those seeking to deepen their understanding and stay abreast of the rapidly evolving landscape in infection research.

Pathogens

Bridging Science and Application in Pathogen Research
Publisher: MDPIISSN: Frequency: 12 issues/year

Pathogens is a leading open-access journal published by MDPI since 2012, dedicated to advancing the understanding of infectious agents and their interactions with hosts in the fields of immunology, microbiology, and molecular biology. Based in Switzerland, this journal plays a crucial role in disseminating high-quality research that spans from fundamental studies of pathogen biology to the implications for global health and disease management. With a commendable impact factor and prestigious Q2 rankings across multiple categories—including Immunology and Microbiology—Pathogens ensures visibility and accessibility for groundbreaking findings. The journal embraces the ethos of open access, allowing researchers, professionals, and students to access critical research anytime, facilitating a collaborative and innovative academic environment. By bridging the gap between research and application, Pathogens is instrumental in shaping the future of infectious disease research and management.

JAPANESE JOURNAL OF INFECTIOUS DISEASES

Pioneering insights for the prevention and control of infections.
Publisher: NATL INST INFECTIOUS DISEASESISSN: 1344-6304Frequency: 6 issues/year

The Japanese Journal of Infectious Diseases, published by the National Institute of Infectious Diseases in Japan, serves as a vital platform for researchers, clinicians, and public health professionals committed to advancing the field of infectious disease science. With an ISSN of 1344-6304 and an E-ISSN of 1884-2836, this journal has maintained its academic rigor since its inception in 1961 and continues to contribute significantly to the global understanding of infectious diseases. The journal holds a Q3 ranking in the categories of Infectious Diseases, Miscellaneous Medicine, and Medical Microbiology as of 2023, reflecting its important role in disseminating impactful research. With many articles available through Open Access, it ensures wide accessibility to the latest discoveries and insights. Researchers can expect to find high-quality studies that address critical challenges in the control and prevention of infectious diseases, making this journal an essential resource for anyone engaging in this critical field.

JOURNAL OF CLINICAL VIROLOGY

Leading the Charge in Virology Research and Treatment
Publisher: ELSEVIERISSN: 1386-6532Frequency: 12 issues/year

Journal of Clinical Virology, published by Elsevier, stands at the forefront of virology research, focusing on the clinical implications of viral diseases. With an impressive impact factor representative of its Q1 categorization in both Infectious Diseases and Virology, this journal is essential for researchers and healthcare professionals aiming to keep pace with evolving knowledge and treatments in virology. Since its inception in 1998, it has provided a vital platform for the dissemination of significant breakthroughs, now continuing through to 2024. The journal boasts competitive Scopus ranks, placing it in the 95th percentile for Infectious Diseases and the 91st percentile for Virology. Scholars can benefit from its selective Open Access options, promoting widespread access to cutting-edge research. With an ever-increasing demand for innovative solutions to viral infections, Journal of Clinical Virology remains dedicated to fostering advancements in the field, making it a key resource for anyone invested in virology and infectious disease management.

Asian Pacific Journal of Tropical Medicine

Exploring the frontiers of tropical medicine in Asia Pacific.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1995-7645Frequency: 12 issues/year

Asian Pacific Journal of Tropical Medicine, published by Wolters Kluwer Medknow Publications, stands at the forefront of research in the field of tropical medicine, contributing significantly to the global understanding of health issues prevalent in the Asian Pacific region. With an ISSN of 1995-7645 and an E-ISSN of 2352-4146, this esteemed journal has been an Open Access platform since 2011, ensuring that vital research is accessible to a broad audience. The journal boasts a commendable Scopus rank of 131 out of 636 in the General Medicine category, placing it in the 79th percentile and recognizing its influential contributions to the discipline. Based in Mumbai, India, the journal spans converged years from 2010 to 2024 and is categorized in the Q3 quartile for miscellaneous medicine as of 2023. Researchers, professionals, and students can leverage this journal to stay abreast of the latest findings and developments in tropical medicine, making it an indispensable resource in their academic and professional pursuits.